The NY Times feels that Merck is losing the Vioxx trial
“Ernst v. Merck, the first Vioxx-related lawsuit to come to trial, is not over yet. But as the company begins to present its case after 14 days of testimony from plaintiffs, Merck appears to be in a deep hole.”
The NY Times feels that Merck is losing the Vioxx trial
Real physician voices, twice a week
Free, and one click to unsubscribe.
Keep reading
The Podcast
Latest episodes
Most popular
Hidden fees in employer health plans are about to come out
Is your clinical AI tool safe? 4 questions to ask first
Alzheimer’s treatment works best early, so why are patients waiting?
Doctors can spot a failing patient. Can they spot a failing hospital?
Clinical trials answer drug questions. Health questions need other tools.
Shy doctors can lead: imposter syndrome and the path to physician leadership
Bringing a newborn home? What hospitals don’t tell new parents
